Nimodipine and Steroid Combination Therapy for Idiopathic Sudden Sensorineural Hearing Loss
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, Jae Joon | - |
dc.contributor.author | Jung, Jae Yeup | - |
dc.contributor.author | Park, Kye Hoon | - |
dc.contributor.author | Lee, Ho Yun | - |
dc.contributor.author | Lee, Byung Don | - |
dc.contributor.author | Choi, Seong Jun | - |
dc.contributor.author | Lee, Chi Kyou | - |
dc.date.accessioned | 2021-08-11T08:34:00Z | - |
dc.date.available | 2021-08-11T08:34:00Z | - |
dc.date.issued | 2020-08 | - |
dc.identifier.issn | 1531-7129 | - |
dc.identifier.issn | 1537-4505 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2585 | - |
dc.description.abstract | Objective: To evaluate the treatment outcomes of nimodipine and steroid combination therapy for idiopathic sudden sensorineural hearing loss (ISSNHL). Study Design: Retrospective case review. Setting: Tertiary referral center. Patients: Seventy-eight patients who were diagnosed with ISSNHL were divided into two group based on the treatment strategies used: steroid+nimodipine (SN, n = 36) and steroid only (SO, n = 42) groups. Based on the level of hearing loss before treatment, subgroup analysis (<90 dB HL, SN-S versus SO-S groups; >= 90 dB HL, SN-P versus SO-P groups) was performed. Interventions: Nimodipine+dexamethasone versus dexamethasone alone. Main Outcome Measures: Hearing thresholds and complete/partial recovery rate after treatment. Results: Hearing thresholds after treatment were not significantly different between the SN and SO groups (46.8 +/- 29.4 versus 54.8 +/- 27.6 dB HL, p = 0.218). However, the complete recovery rate was significantly higher in the SN group than in the SO group ( 41.7% versus 16.8%, p = 0.014). In subgroup analysis, the complete recovery rate was significantly higher in the SN-S group than in the SO-S group (60.9% versus 19.2%, p = 0.003), whereas the difference between the SN-P and SO-P groups was not significant (7.7% versus 12.5%, p = 0.672). The cumulative incidence of complete recovery was significantly higher in SN-S group than in the SO-S group (p = 0.005); the mean recovery time was 4.4 weeks (95% confidence interval [CI], 2.8-6.1) in the SN-S group and 8.8 weeks (95% CI, 7.0-10.5) in the SO-S group. Conclusions: The results of this study suggest that nimodipine and steroid combination therapy for ISSNHL results in a higher complete recovery rate than steroid alone in patients with moderate to severe hearing loss. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | Nimodipine and Steroid Combination Therapy for Idiopathic Sudden Sensorineural Hearing Loss | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1097/MAO.0000000000002695 | - |
dc.identifier.scopusid | 2-s2.0-85088486525 | - |
dc.identifier.wosid | 000619253000003 | - |
dc.identifier.bibliographicCitation | Otology and Neurotology, v.41, no.7, pp E783 - E789 | - |
dc.citation.title | Otology and Neurotology | - |
dc.citation.volume | 41 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | E783 | - |
dc.citation.endPage | E789 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Otorhinolaryngology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Otorhinolaryngology | - |
dc.subject.keywordAuthor | Hearing recovery | - |
dc.subject.keywordAuthor | Nimodipine | - |
dc.subject.keywordAuthor | Steroid | - |
dc.subject.keywordAuthor | Sudden hearing loss | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.